Journal article

Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care

Joshua ML Casan, Alison Barraclough, Jake Shortt, Eliza A Hawkes

The Lancet Haematology | ELSEVIER SCI LTD | Published : 2019

DOI: 10.1016/S2352-3026(19)30013-4

Keywords

Etoposide
Prednisone
Hematology
Doxorubicin
Rituximab
Humans
Antineoplastic Combined Chemotherapy Protocols
Standard of Care
Life Sciences & Biomedicine
Science & Technology
Multicenter
Vincristine
Cyclophosphamide
Lymphoma, Large B-Cell, Diffuse
Prospective Studies